Skip to content

Comparative evaluation of lidocaine 0.5% and lidocaine 0.25% with pethidine for intravenous regional anesthesia in upper limb soft tissue surgery

Comparative evaluation of lidocaine 0.5% and lidocaine 0.25% with pethidine for intravenous regional anesthesia in upper limb soft tissue surgery

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20141009019470N115
Enrollment
50
Registered
2021-04-13
Start date
2021-04-19
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

upper limb surgeries. Traumatic compartment syndrome of left upper extremity, subsequent encounter

Interventions

Intervention 1: Intervention group:Patients in the first intervention group will receive 3 mg / kg lidocaine 2% in 40 cc syringe for biers block. Intervention 2: Intervention group: Patients in the se

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 18 to 60 years old, Patients Candidate for Upper Limb Surgery ASA One and Two

Exclusion criteria

Exclusion criteria: Heart disease High blood pressure and low blood pressure Bradycardia Hyperthyroidism Cardiac block Using Adrenoceptor agonist and antagonist Peripheral neuropathy Pregnancy Addiction Allergy to the drugs used in the study Coagulation Disorders Topical infections Patient refusal Problems and deformities of musculoskeletal of the upper limb

Design outcomes

Primary

MeasureTime frame
Evaluation of the blocks of sensory nerves within the four main branches of the hand nerve. Timepoint: Every 30 seconds. Method of measurement: Pin prick Test.;Evaluation of motor nerve block. Timepoint: Every 30 seconds. Method of measurement: Assessment of flexion and extension ability of wrists and fingers.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHeidar Safari

Shiraz University of Medical Sciences

heidarsafari2031365@gmail.com+98 71 3647 4270

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026